Filter Results
:
(7,932)
Show Results For
-
All HBS Web
(7,932)
- People (21)
- News (2,550)
- Research (4,039)
- Events (18)
- Multimedia (276)
- Faculty Publications (3,288)
Show Results For
-
All HBS Web
(7,932)
- People (21)
- News (2,550)
- Research (4,039)
- Events (18)
- Multimedia (276)
- Faculty Publications (3,288)
- Article
The Business of Medicine in the Era of COVID-19
By: David M. Cutler, Sayeh Nikpay and Robert S. Huckman
This Viewpoint discusses the shifting landscape of health care financing, regulation, and delivery as a result of the coronavirus pandemic, and discusses regulatory and other changes that need to be in place if telehealth and physician practice and hospital mergers...
View Details
Keywords:
Health Care;
COVID-19;
Telemedicine;
Business;
Health Pandemics;
Health Care and Treatment;
Change;
Competition
Cutler, David M., Sayeh Nikpay, and Robert S. Huckman. "The Business of Medicine in the Era of COVID-19." JAMA, the Journal of the American Medical Association 323, no. 20 (May 26, 2020): 2003–2004.
- 1995
- Chapter
Contending Views of Quality Management in Health Care: Implications for Competition and Regulation
By: D. Blumenthal and Richard Bohmer
- February 2021
- Case
New England Baptist Hospital: Getting Paid for Value
By: Robert S. Kaplan, Mary Witkowski, Toby E. Emanuel and Syed S. Shehab
New England Baptist Hospital (NEBH), a national leader in adult orthopedic care, has the lowest rate of complications and 30-day readmissions in New England, but gets paid 30% less for its surgeries than nearby institutions. NEBH introduces, with several large...
View Details
Keywords:
Healthcare;
Healthcare Spending;
Healthcare Innovation;
Healthcare Industry;
Health Care Outcomes;
Health Care Delivery;
Health Care Reform;
Bundled Payments;
Health Care and Treatment;
Spending;
Innovation and Invention;
Value Creation;
Strategy;
Health Industry;
North America
Kaplan, Robert S., Mary Witkowski, Toby E. Emanuel, and Syed S. Shehab. "New England Baptist Hospital: Getting Paid for Value." Harvard Business School Case 121-036, February 2021.
- August 2020
- Article
A History of Prescription Drug Monitoring Programs in the United States: Political Appeal and Public Health Efficacy
By: A Jay Holmgren, Alyssa Botelho and Allan M Brandt
Prescription drug monitoring programs (PDMPs) have become a widely embraced policy to address the US opioid crisis. Despite mixed scientific evidence on their effectiveness at improving health and reducing overdose deaths, 49 states and Washington, DC have adopted...
View Details
Keywords:
Health Disorders;
Information Technology;
Programs;
Technology Adoption;
History;
Government and Politics;
Policy;
United States
Holmgren, A Jay, Alyssa Botelho, and Allan M Brandt. "A History of Prescription Drug Monitoring Programs in the United States: Political Appeal and Public Health Efficacy." American Journal of Public Health 110, no. 8 (August 2020).
- 17 Jun 2021
- News
Too Few Women Get to Invent – That’s a Problem for Women’s Health
- April 5, 2023
- Article
We Need an Operation Warp Speed for Long COVID
By: Esther K. Choo and Scott Duke Kominers
With millions of people affected and at least $1 trillion of economic value at stake, long COVID is our next national health emergency.
View Details
Keywords:
COVID;
COVID-19;
COVID-19 Pandemic;
Scientific Research;
Policy;
Health Policy;
Innovation;
Science;
Public Finance;
Public Health;
Health Disorders;
Health Care and Treatment;
Human Capital
Choo, Esther K., and Scott Duke Kominers. "We Need an Operation Warp Speed for Long COVID." Scientific American (website) (April 5, 2023).
- April 1996 (Revised March 1998)
- Supplement
Starlite: Confidential Instructions for S. Mason, VP of HR Health Sciences Division
By: Kathleen L. McGinn and Julia Morgan
Supplements Starlite Corp.: General Information.
View Details
McGinn, Kathleen L., and Julia Morgan. "Starlite: Confidential Instructions for S. Mason, VP of HR Health Sciences Division." Harvard Business School Supplement 396-356, April 1996. (Revised March 1998.)
- April 2021
- Case
ClearChoice Dental Implant Centers
By: Robert S. Kaplan, Ashiana Jivraj and Jane Barrow
The case illustrates the application of value-based health care to dental medicine. ClearChoice Dental Implant Centers was a rapidly-growing network of dentist-owned independent implant clinics. The targeted market included 23 million people, 15% of the US adult...
View Details
Keywords:
Value-based Health Care;
Dental Medicine;
Growth and Development Strategy;
Expansion;
Business Strategy;
Customer Value and Value Chain;
Customer Focus and Relationships;
Health Industry;
United States
Kaplan, Robert S., Ashiana Jivraj, and Jane Barrow. "ClearChoice Dental Implant Centers." Harvard Business School Case 121-082, April 2021.
- Article
Why Apps for Managing Chronic Disease Haven't Been Widely Used, and How to Fix It
By: Robert S. Huckman and Ariel Dora Stern
Keywords:
Health Care;
Digital Health;
Chronic Disease;
App;
Health Information Technology;
Information Technology;
Health Industry;
United States
Huckman, Robert S., and Ariel Dora Stern. "Why Apps for Managing Chronic Disease Haven't Been Widely Used, and How to Fix It." Harvard Business Review (website) (April 4, 2018).
- January 2014 (Revised June 2014)
- Case
23andMe: Genetic Testing for Consumers (A)
By: John A. Quelch and Margaret L. Rodriguez
On November 22, 2013, the direct-to-consumer genetic testing provider, 23andMe, received a letter from the U.S. Food and Drug Administration (FDA) ordering the company to halt the sale and promotion of its genetic testing kit. The FDA stated that the product was...
View Details
Keywords:
Public Health;
Genome Testing;
Health Care;
Ancestry;
23andMe;
Marketing;
Product Launch;
Health;
Health Care and Treatment;
Health Testing and Trials;
Genetics;
Strategy;
Health Industry;
United States
Quelch, John A., and Margaret L. Rodriguez. "23andMe: Genetic Testing for Consumers (A)." Harvard Business School Case 514-086, January 2014. (Revised June 2014.)
- December 2022
- Article
Cost Standard Set Program: Moving Forward to Standardization of Cost Assessment Based on Clinical Condition
By: Anna Paula Beck da Silva Etges, Richard D. Urman, Anne Geubelle, Robert Kaplan and Carisi Anne Polanczyk
This communication announces the International Cost Standard Set Program. Its goal is to establish global standardized frameworks for measuring the costs of treating specific clinical conditions. A scientific committee, including 16 international healthcare cost...
View Details
Keywords:
Time-Driven Activity-Based Costing;
Value-based Health Care;
Cost;
Health Care and Treatment;
Activity Based Costing and Management;
Health Industry
da Silva Etges, Anna Paula Beck, Richard D. Urman, Anne Geubelle, Robert Kaplan, and Carisi Anne Polanczyk. "Cost Standard Set Program: Moving Forward to Standardization of Cost Assessment Based on Clinical Condition." Journal of Comparative Effectiveness Research 11, no. 17 (December 2022): 1219–1223.
- Article
Europe's Alternative to Medicare for All: Swiss and Dutch Private Insurance Provide Better Coverage Than Canada's Single-Payer System
By: Regina E. Herzlinger and Bacchus Barua
An analysis of Canada’s single-payer healthcare system shows the dangers of the proposed Medicare for All model. In fact, the Canadian healthcare system is costly and drives poor outcomes when compared to objective performance measures. Alternatively, the Swiss and...
View Details
Keywords:
Healthcare Systems;
Universal Health Coverage;
Health Care and Treatment;
Insurance;
Canada;
Switzerland;
Netherlands
Herzlinger, Regina E., and Bacchus Barua. "Europe's Alternative to Medicare for All: Swiss and Dutch Private Insurance Provide Better Coverage Than Canada's Single-Payer System." Wall Street Journal (April 17, 2019).